RankingsPricing
  1. US-listed companies
  2. BALCHEM CORP
  3. Financials
  4. Research & development

BALCHEM CORPBCPC

Market cap
$5.2B
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 202417+11.59%
Dec 31, 202315+23.44%
Dec 31, 202212-9.86%
Dec 31, 202114+30.89%
Dec 31, 202010-9.19%
Dec 31, 201911-1.85%
Dec 31, 201812+24.58%
Dec 31, 20179+27.03%
Dec 31, 20167+22.29%
Dec 31, 20156+24.53%
Dec 31, 20145+32.80%
Dec 31, 20134+5.84%
Dec 31, 20123+18.41%
Dec 31, 20113

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)